Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

NCT02661542 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Lymphomas

Interventions

DRUG: FF-10502-01

Sponsor

Fujifilm Pharmaceuticals U.S.A., Inc.